Annis Gardner Whiting Capital Advisors, LLC Haemonetics Corp Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $236 Billion
- Q1 2025
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 188 shares of HAE stock, worth $13,549. This represents 0.01% of its overall portfolio holdings.
Number of Shares
188
Previous 188
-0.0%
Holding current value
$13,549
Previous $14.7 Million
18.61%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HAE
# of Institutions
351Shares Held
53.3MCall Options Held
417KPut Options Held
314K-
Black Rock Inc. New York, NY5.96MShares$429 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$368 Million0.01% of portfolio
-
Neuberger Berman Group LLC New York, NY4.35MShares$313 Million0.24% of portfolio
-
Wellington Management Group LLP Boston, MA2.62MShares$189 Million0.03% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.2MShares$158 Million0.09% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $3.7B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...